• A Baldini, H Fassi Fehri, Y Cerantola, F Bayle, E Ravier, P Y Belot, N Arnouil, M Colombel, and L Badet.
• Hôpital Édouard-Herriot, 5, place d'Arsonval, 69003 Lyon, France. Electronic address: abaldini@hotmail.fr.
• Prog Urol. 2018 May 1; 28 (6): 351-358.

ObjectiveTo estimate the feasibility and the impact of an ERAS program after radical cystectomy for bladder cancer.Materials And MethodsThis was a retrospective study comparing a historical pre ERAS group, including all the patients undergoing cystectomy for bladder cancer from January 2013 to December 2015 with a classic procedure, and an interventional ERAS group after introducing an enhanced recovery protocol before, during and after surgery, from February 2016. The principal outcome was the postoperative length of stay. Secondary outcomes mesures were impact on perioperative complication rate (Clavien classification≥3B), readmission rate, reanimation length of stay, ileus rate and adherence to the ERAS protocol.ResultsThere were no differences between the 2 groups as far as demographics characteristics are concerned. In total, 97 patients were included, 56 in the control group, and 41 in the ERAS group. The adherence to the protocol was about 65.8%. The ERAS group had statistically significantly shorter median length of stay (D19 versus D14; P: 0.021). The major complications rate (Clavien≥3B) were about 23.2% for the control group and 12.1% for the ERAS group (P: NS). The reinsertion of nasogastric tube were higher in the control group (39.3% vs 21.9%; P: NS) and the readmission rate was about 7.1% in the control group versus 14.6% in the ERAS group (P: NS).ConclusionIn conclusion, introduction and application of an enhanced recovery protocol (ERAS) after cystectomy for bladder cancer allowed for better management of postoperative outcomes. It is clearly feasible in cystectomy, and improve significantly the median postoperative length of stay. Moreover, it may be effective in terms of faster return of bowel function and reduction of majors complications.Level Of Evidence4.Copyright © 2018 Elsevier Masson SAS. All rights reserved.

34 keywords...

hide…